Delta-aminolevulinic acid dehydratase-porphyria (ADP) is an autosomal recessive disorder of heme biosynthesis, caused by delta-aminolevulinic acid dehydratase deficiency (ALAD).(1) We report an important change in pathophysiological concepts and subsequent therapeutic options for patients with ADP, based on a review of previous cases and the treatment effects in a reported case.

Additional Metadata
Persistent URL dx.doi.org/10.1002/hep.30543, hdl.handle.net/1765/118224
Journal Hepatology
Citation
Neeleman, R.A., van Beers, E.J, Friesema, E.C.H, Koole-Lesuis, R., van der Pol, W.-L, Wilson, J.H.P, & Langendonk, J.G. (2019). Clinical Remission of Delta-Aminolevulinic Acid Dehydratase Deficiency Through Suppression of Erythroid Heme Synthesis. Hepatology, 70(1), 434–436. doi:10.1002/hep.30543